SVRA Bathi mangsa ngarep Savara Inc

Savara Corp - logo grafis emiten SVRA

Expected profit dynamics for Savara Inc. (SVRA) indicate growth following the launch of an orphan drug, as operating expenses transition into revenues. The value stabilized at , confirming market optimism. The potential of Savara Inc. (SVRA) is based on its monopoly in treating rare lung pathologies, although development is hindered by risks of global supply chain disruptions and complexities regarding the protection of international patents.

SVRA: Prakiraan bathi perusahaan Savara Inc. 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Savara Inc.

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:SVRA, Savara Corp
Barang utama Savara Pharma

For Savara Inc. (SVRA), whose biologics are transitioning to the commercialization stage, calculating future return on capital is critical to eliminate the risk of acquiring a deteriorating asset. By analyzing expected profit margins on GURU.Markets, an investor assesses the mathematical probability of monetizing innovations in the treatment of rare lung pathologies, which allows for the verification of the company's fundamental value and prevents overpaying for unjustified expectations.

Perusahaan pesaing

ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep PTGX (protagonist-inc.com)|Prakiraan bathi perusahaan immunovant.com (IMVT)|KNSA - Bathi sing dikarepake|Grifols SA (GRFS) - Bathi mangsa ngarep|Adaptive Biotechnologies Inc. (ADPT) - Bathi sing dikarepake|Bathi mangsa ngarep Celldex Therapeutics|Bathi mangsa ngarep AUPH|Proyeksi bathi mangsa ngarep biocryst.com|Bathi sing dikarepake Vera Pharma (VERA)|Dianthus Therapeutics, Inc. - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep PHVS (pharvaris.com)|AbCellera Bio (ABCL) - Bathi resik sing dikarepake|TRML: Bathi mangsa ngarep|Bathi forward PGEN|PHAR: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Nektar Therapeutics Inc (NKTR)|Bathi mangsa ngarep UPB|Prakiraan bathi resik ZBIO (Zenas Biopharma, Inc.)|Bathi mangsa ngarep IMNM (Immunome Bio)|Prakiraan bathi perusahaan Gossamer Bio, Inc.|Proyeksi bathi mangsa ngarep KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Bathi resik sing dikarepake|PVLA - Bathi sing dikarepake|Penghasilan resik sing dikarepake RIGL (Rigel Corp)|anaptysbio.com (ANAB) - Bathi sing dikarepake|Astria Therapeutics, Inc. - Penghasilan resik sing dikarepake|ENGN (enGene) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake RAPT Therapeutics Inc. RAPT|Bathi mangsa ngarep JBIO (Aerovate Therapeutics, Inc.)|Bathi resik mangsa ngarep ACRS|Proyeksi bathi mangsa ngarep KYTX (Kyverna Therapeutics)|Prakiraan bathi perusahaan Tiziana Life Sciences (TLSA)|Cabaletta Bio - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Ventyx Biosciences, Inc. VTYX|Theratechnologies Inc (THTX) - Bathi sing dikarepake|Bathi forward AVTX (Avalo Therapeutics Inc.)|ELDN (Eledon Pharmaceuticals, Inc) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep agenusbio.com|Proyeksi bathi mangsa ngarep CLYM|Bathi resik mangsa ngarep ZURA|Proyeksi bathi mangsa ngarep ATYR (aTyr Pharmaceuticals)|Penghasilan resik sing dikarepake ADAG|ImageneBio Inc - Proyeksi bathi mangsa ngarep|STTK (shattucklabs.com) - Prakiraan bathi resik|EQ: Proyeksi bathi mangsa ngarep|Connect Biopharma Holdings (CNTB) - Proyeksi bathi mangsa ngarep|IMUX (immunic-therapeutics.com) - Proyeksi bathi mangsa ngarep|ATRA (Atara Biotherapeutics) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep IFRX|Proyeksi bathi mangsa ngarep X4 Pharmaceuticals, Inc (XFOR)|Proyeksi bathi mangsa ngarep ACET (Adicet Bio Inc.)|CELU (Celularity Corp) - Bathi forward|INmune Bio Corp - Proyeksi bathi mangsa ngarep|BRNS - Proyeksi bathi mangsa ngarep|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|SABS (sabbiotherapeutics.com) - Bathi sing dikarepake|Bathi sing dikarepake Akari Therapeutics|Bathi sing dikarepake ENLV|Bathi sing dikarepake Q32 Bio Inc (QTTB)|GOVX (GeoVax Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep EDSA (Edesa Biotech Corp)|IBIO: Prakiraan bathi resik|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep